CONNECTICUT CHILDRENS MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4.8M
- Transactions
- 1,181
- Companies
- 40
- Average per transaction
- $4,050
Who reported the payments
| Janssen Research & Development, LLC | $725,470 |
| Ultragenyx Pharmaceutical Inc. | $518,568 |
| Jazz Pharmaceuticals Inc. | $507,166 |
| Biogen | $427,889 |
| Pfizer | $418,639 |
| Eli Lilly | $297,907 |
| Sarepta Therapeutics, Inc. | $257,652 |
| AbbVie | $254,492 |
| Takeda Pharmaceuticals U.S.A., Inc. | $225,705 |
| AstraZeneca | $130,853 |
| Chiesi USA, Inc. | $103,866 |
| Shire North American Group Inc | $95,827 |
| E.r. Squibb & Sons, L.L.C. | $86,120 |
| Amgen | $63,563 |
| GW Research Limited | $56,571 |
| SK Life Science, Inc. | $52,667 |
| Day One Biopharmaceuticals | $42,080 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | $42,032 |
| Vertex | $41,629 |
| Biohaven Pharmaceutical Holding Company Ltd. | $41,300 |
| Sanofi Pasteur Inc. | $40,825 |
| Ardelyx, Inc. | $39,500 |
| Neurocrine Biosciences, Inc. | $37,452 |
| Novartis | $37,309 |
| Biomarin Pharmaceutical Inc. | $32,228 |
| Bristol Myers Squibb | $32,000 |
| Linde Gas & Equipment Inc. | $31,463 |
| ITF Therapeutics LLC | $29,396 |
| Incyte Corporation | $19,018 |
| UCB SA | $17,450 |
| Novo Nordisk AS | $15,947 |
| Merck | $14,365 |
| Smith+Nephew | $12,937 |
| CSL Behring | $9,245 |
| KCI USA, Inc. | $7,125 |
| Nonin Medical, Inc. | $2,216 |
| Siemens Medical Solutions USA, Inc. | $1,912 |
| Stryker | $1,823 |
| Vivus LLC | $1,728 |
| Kyowa Kirin, Inc. | $1,451 |